Lexicon Pharmaceuticals (LXRX) Return on Capital Employed Growth (1y) (2012 - 2026)
Lexicon Pharmaceuticals (LXRX) Return on Capital Employed Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,094.26 Bn | 68,093.97 Bn | - | 1,648.00 |
| 2 | Nanobiotix | 1,939.09 Bn | 1,939.02 Bn | - | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - | 31,429.00 |
| 4 | BeOne Medicines | 473.53 Bn | 468.74 Bn | 1.35 Bn | 1,805.00 |
| 5 | Vertex Pharmaceuticals | 123.34 Bn | 116.09 Bn | 2.59 Bn | 2,503.00 |
| 6 | Regeneron Pharmaceuticals | 70.13 Bn | 61.38 Bn | 3.31 Bn | -105.00 |
| 7 | Belite Bio | 62.96 Bn | 62.96 Bn | - | - |
| 8 | Argenx Se | 56.38 Bn | 51.20 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.67 Bn | 34.66 Bn | 959.66 Mn | 2,400.00 |
| 10 | Lexicon Pharmaceuticals | 938.56 Mn | 767.90 Mn | 20.99 Mn | 8,356.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8,356.00 |
| Dec 31, 2025 | 4,650.00 |
| Sep 30, 2025 | 3,338.00 |
| Jun 30, 2025 | 144.00 |
| Mar 31, 2025 | -3,273.00 |
| Dec 31, 2024 | 305.00 |
| Sep 30, 2024 | -909.00 |
| Jun 30, 2024 | 664.00 |
| Mar 31, 2024 | 663.00 |
| Dec 31, 2023 | -1,824.00 |
| Sep 30, 2023 | 1,299.00 |
| Jun 30, 2023 | 2,882.00 |
| Mar 31, 2023 | 757.00 |
| Dec 31, 2022 | 640.00 |
| Sep 30, 2022 | -2,149.00 |
| Jun 30, 2022 | -11,610.00 |
| Mar 31, 2022 | -7,230.00 |
| Dec 31, 2021 | -3,266.00 |
| Sep 30, 2021 | 71.00 |
| Jun 30, 2021 | 675.00 |